At a glance
ClinicalIndex Comparison RecordN/ACompleted· 63 enrolled
Drug / intervention
Received the GS-SHEPbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of a Gender-sensitive Sexual Health Education Program for Women With Gynecologic Cancer: A Prospective and Randomized Controlled Evaluation of Sexual Health Education Program of Cervical Cancer Women
In Brief
A clinical study evaluating Received the GS-SHEP for Sexual Health. Completed, enrolled 63 participants across 1 site.
Detailed Summary
The purpose of this study was to evaluate the effectiveness of the Gender-Sensitive -Sexual Health Education Program (GS-SHEP) in enhancing the sexual health of patients with gynecologic cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSexual Health
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMar 2017
Primary CompletionJun 2018
Study CompletionDec 2018
First PostedMar 2023
TodayJul 2026
First PostedMar 16, 2023
Enrollment StartMar 26, 2017
Primary CompletionJun 26, 2018
Study CompletionDec 26, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.3 years ago
Interventions
Received the GS-SHEPbehavioral
The experimental group (n=33) received the GS-SHEP (a 10-15-minute individual sexual health education and a sexual health pamphlet). GS-SHEP effectiveness was examined using a self-report instrument to measure background information and three dependent variables: "sexual knowledge," "sexual attitudes," and "sexual self-efficacy."